SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

37.8863463

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

82.26

2029.15

EPS(TTM)

Face Value()

Div & Yield %

5.97

0.08

Back

premier ltd

Sagar Cements reports consolidated net loss of Rs 57.58 crore in the December 2025 quarter

Jan 22,2026

Net Loss of Sagar Cements reported to Rs 57.58 crore in the quarter ended December 2025 as against net loss of Rs 55.07 crore during the previous quarter ended December 2024. Sales rose 4.73% to Rs 590.54 crore in the quarter ended December 2025 as against Rs 563.88 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	590.54	563.88	5
OPM %	6.38	6.68	-
PBDT	-10.79	-5.62	-92
PBT	-73.83	-64.23	-15
NP	-57.58	-55.07	-5

76,664.21 -999.79 ( -1.29%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)